1. Stocks
    2. /
  2. Johnson & Johnson (NYSE: JNJ)
    3. /

Johnson & Johnson (NYSE: JNJ) Share Price and News

$154.00 $2.13 (1.4%) Saturday, 16 November 2024 at 8:00:00 am Australian Eastern Daylight Time

Johnson & Johnson Chart and Price Data

About Johnson & Johnson

Last updated 16-11-2024, 08:00:00am AEDT
Current Price $154.00
Change $2.13 (1.4%)
Close Price $154.00
Open Price $150.90
Bid $154.00
Ask $154.20
Day Range $150.90 - $154.43
Year Range $143.13 - $168.85
Volume 11,328,515
Average Volume 6,198,682
Market Cap $370,773,480,000.00
Earnings Per Share $6.05

    • Johnson & Johnson (NYSE: JNJ)
    Latest News

    CSL share price represented by hand in blue glove picks out a vial labelled 'covid-19 vaccine' from a row of vials
    International Stock News

    Coronavirus vaccine race: 7 key things you'll want to know

    | Keith Speights

    Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

    Read more »

    A businessman holding a world globe in one hand, representing global investment.
    Technology Shares

    3 exotic ASX tech ETFs you might want to add to your portfolio today

    | Sebastian Bowen

    Want exposure to tech shares? Feeling offput by high valuations? Use these 3 ASX tech ETFs to solve these problems…

    Read more »

    International Stock News

    How to invest in coronavirus vaccine stocks

    | Keith Speights

    Just follow these three simple steps.

    Read more »

    woman sitting at desk looking at calculator
    International Stock News

    This is the one investment Warren Buffett says almost everyone should make

    | Christy Bieber

    His advice is simple and easy to follow.

    Read more »

    Blue gloved hands holding up vials with covid vaccine labels
    International Stock News

    In the race for a coronavirus vaccine, can there be multiple winners?

    | Adria Cimino

    Demand says we may need several players crossing the finish line.

    Read more »

    International Stock News

    Johnson & Johnson to launch late-stage coronavirus vaccine trials in September

    | Eric Volkman

    The company aims to recruit 60,000 participants for the study.

    Read more »

    International Stock News

    This could be the ace in the hole for Johnson & Johnson's COVID-19 vaccine

    | Keith Speights

    J&J is behind in the race to develop a COVID-19 vaccine. But there's one thing that could make it a…

    Read more »

    International Stock News

    Everything you need to know about the coronavirus vaccine race

    | Keith Speights

    Here are your answers to the questions that matter the most about COVID-19 vaccines in development

    Read more »

    Profile

    since

    Note